The University of Notre Dame Australia

ResearchOnline@ND
Medical Papers and Journal Articles

School of Medicine

2019

Trans-generational stress regulation: Mother-infant cortisol and maternal
mental health across the perinatal period
Megan Galbally
The University of Notre Dame Australia, megan.galbally@nd.edu.au

Elisabeth F.C van Rossum
Stuart J. Watson
The University of Notre Dame Australia, stuart.watson@nd.edu.au

Edo Ronald de Kloet
Andrew J. Lewis

Follow this and additional works at: https://researchonline.nd.edu.au/med_article
Part of the Medicine and Health Sciences Commons
This article was originally published as:
Galbally, M., van Rossum, E. F., Watson, S. J., de Kloet, E. R., & Lewis, A. J. (2019). Trans-generational stress regulation: Mother-infant
cortisol and maternal mental health across the perinatal period. Psychoneuroendocrinology, 109.
Original article available here:
https://doi.org/10.1016/j.psyneuen.2019.104374

This article is posted on ResearchOnline@ND at
https://researchonline.nd.edu.au/med_article/1064. For more
information, please contact researchonline@nd.edu.au.

©2019. This manuscript version is made available under the CC-BY-NC-ND 4.0 International
license http://creativecommons.org/licenses/by-nc-nd/4.0/

This is the accepted manuscript version of an article published as:
Galbally, M., van Rossum, E.F.C., Watson, S.J., de Kloet, E.R., and Lewis, A.J. (2019). Transgenerational stress regulation: Mother-infant cortisol and maternal mental health across the
perinatal period. Psychoneuroendocrinology, 109. doi: 10.1016/j.psyneuen.2019.104374
This article has been published in final form at https://doi.org/10.1016/j.psyneuen.2019.104374

1
Trans-generational stress regulation: mother-infant cortisol and maternal mental health across
the perinatal period.
Megan Galbally MBBS, PhD1,2,3,
Elisabeth F.C. van Rossum MD PhD4,
Stuart J Watson PhD1,2,
Edo Ronald de Kloet PhD5,
Andrew J. Lewis PhD1

Author Affiliations:
1.

School of Psychology and Exercise Science, Murdoch University, Australia

2.

School of Medicine, University of Notre Dame, Australia

3.

King Edward Memorial Hospital, Australia

4.

Department of Internal Medicine, Division of Endocrinology, Erasmus MC, University
Medical Center Rotterdam, Rotterdam, The Netherlands

5.

Department of Medicine, Division of Endocrinology, Leiden University Medical Center,
Leiden, The Netherlands

Corresponding Author:
Professor Megan Galbally Murdoch University, 90- South Street, Murdoch 6150
Email: m.galbally@murdoch.edu.au Ph +61-8-9340 2844

2
Highlights


Antenatal depression and cortisol may be important for developing infant stress regulation.



Hair cortisol concentrations are useful for measuring cortisol in pregnancy and the
postpartum.



Maternal hair cortisol concentration across pregnancy was not associated with maternal
depression.



Antenatal maternal depressive symptoms were both associated with lower infant cortisol at 12
months of age.



Lower infant cortisol reactivity was associated with higher infant externalizing symptoms.
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Abstract

Understanding maternal mental health and cortisol regulation across pregnancy and the
relationship to the development of the offspring’s stress regulation is critical to a range of
health outcomes. The aim of this study was to investigate infant and maternal cortisol in
women with depression. Data were obtained from 241 pregnant women within Mercy
Pregnancy and Emotional Wellbeing Study (MPEWS), a selected pregnancy cohort study.
Depression was measured using the Structured Clinical Interview for DSM-IV (SCID-IV)
and repeat Edinburgh Postnatal Depression Scale (EPDS). Repeated measures of
antidepressant use, stressful events, anxiety symptoms and maternal hair cortisol
concentrations (HCC) and infant cortisol at 12 months postpartum in saliva and hair. Socioemotional outcomes were measured at 12 months by maternal report on the Brief Infant and
Toddler Socio-emotional Assessment (BITSEA). This study found that maternal depression
was not associated with maternal HCC. Anxiety, stress and antidepressant use were not
associated with maternal HCC. Independently higher maternal 3rd trimester maternal
depressive and anxiety symptoms were associated with lower infant cortisol response at 12
months of age. A higher number of postpartum stressful events was associated with lower
infant cortisol response. Lower infant stress reactivity was associated with higher
externalizing symptoms at 12 months of age. Future studies are required to understand
implications for later mental health.
Keywords: Depression, Antidepressants, Pregnancy, Cortisol, Hair, Child Mental Health
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1. Introduction
Research continues to show that maternal perinatal depression predicts less than optimal
child outcomes, including a range of child mental health problems [1, 2]. However, there is
less certainty as to the potential mechanism for this transmission [2]. The relationship
between the experience of stress and the vulnerability to depression is well established and
theoretically, it is suggested that the earlier the exposure to stress the stronger the relationship
[3, 4]. Clearly, such findings point to a possible role of the hypothalamic pituitary adrenal
(HPA) axis where maternal mental health and cortisol regulation may play an early role in
fetal neurodevelopment and subsequent vulnerability for child socio-emotional and
developmental outcomes [5]. Understanding the interaction between maternal depression and
cortisol in pregnancy and how this might influence the development of infant stress
regulation is the first step in then understanding a potential fetal programming pathway
across early life that may influence vulnerability to later psychopathology [6, 7].
A recent review of cortisol and perinatal depression identified 47 relevant studies but one
of the key findings was the considerable variation in measurement of cortisol and the frequent
reliance on screening self-report measures for depressive symptoms [8]. Only four studies
identified in this review were rated as high quality through meeting minimum criteria for
measurement of cortisol. This review found that hypercortisolemia was associated with an
increase in short-term depressive symptoms in the early postpartum and hypocortisolemia
was associated with chronic depressive symptoms. A major limitation identified within this
review was a paucity of studies that utilized diagnostic measures for mental health and use of
community samples with low rates of clinically significant symptoms.
Notably none of the studies identified in the Seth et al review utilized hair cortisol
measurement. There are a number of significant advantages of hair for examination of
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cortisol. Hair can be more consistently collected than saliva or urine, since it will not be as
affected by short-term environmental influences and provides average cortisol levels across
time [9]. A systematic review has examined the emerging research examining hair cortisol
and prenatal distress [10]. This included perceived stress, symptoms of anxiety or depression
or pregnancy related stress. The review identified 6 studies, none used diagnostic measures of
mental disorders, all drew samples from a community with low levels of symptoms of mental
illness and only one study used an additional measure of cortisol in conjunction with hair
cortisol [10, 11]. Of note the two studies that found an association between hair cortisol and
distress utilized hair samples collected in pregnancy. Furthermore, separately both maternal
emotional health in pregnancy and pregnancy cortisol have been associated with later child
cortisol functioning [12, 13].
A review of research that has examined the link between adverse early experiences and
child psychopathology has highlighted the importance of understanding cortisol regulation in
infants as a potential pathway from early exposures to later vulnerability to psychopathology
[16]. While findings have been mixed there have across several studies been trends to suggest
increased levels may be associated with vulnerability to internalizing disorders and a clearer
association with reduced cortisol associated with externalizing disorders [16-18]. The HPA
system and cortisol response change substantially over the first year of life with some
stability and lower responsiveness to everyday stressors only being achieved around 12
months of age supporting measurement of infant cortisol at 12 months or older [4, 5].
While it is important to understand the potential influence of maternal psychopathology
on maternal and infant cortisol over the perinatal period, it is equally important to understand
the impact of treatments. Yet none of these recent reviews of perinatal distress and depression
and cortisol have reported on perinatal antidepressant use and cortisol despite the widespread
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use of antidepressants to treat depression and anxiety in pregnancy [19]. Antidepressant
treatment has been found to alter HPA functioning and impact cortisol levels [20, 21].
In our study, we firstly aim to examine the relationship between maternal hair cortisol
concentrations (HCC) and depression across pregnancy and 12 months postpartum. In
addition, we will examine if antenatal HCC is associated with antidepressant use in
pregnancy. Secondly, we aim to test our hypothesis that maternal HCC across the perinatal
period will predict infant HCC and salivary cortisol response and reactivity. Thirdly, we test
the hypothesis that maternal mental health in pregnancy will be indirectly associated with
infant cortisol (both HCC and cortisol reactivity at 12 months postpartum) through maternal
cortisol. Finally we examine if infant cortisol measures are associated with externalizing or
internalizing symptoms at 12 months of age.
2. Materials and Methods
This is a prospective cohort study of 241 pregnant women recruited before 20 weeks of
pregnancy (Wave 1), and followed up during third trimester (Wave 2), at delivery (Wave 3),
six months (Wave 4) and 12 months (Wave 5). Data was excluded from the study if
participants had withdrawn prior to or after Wave 3, if they were missing both postpartum
waves, or if they had no hair cortisol concentration data. Women who reported taking oral
steroid medication were excluded (n = 3). Study participants comprised two groups those
with depression at recruitment (Depressed; n = 51), and control women (n = 190). Further
details of the study are described in the published study protocol [22]. Demographic data and
information on physical health, pregnancy complications and outcomes, body mass index,
smoking, alcohol and illicit drug use were collected. In addition, infant sex is reported for this
paper. The demographic characteristics of the sample analysed here do not differ significantly
to the full baseline MPEWS cohort (n = 282) demographic characteristics reported in the
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published study protocol. Mercy Health Human Research Ethics Committee approved this
study and all participants provided informed, written consent.
2.1 Measures
2.1.1 Mental Health
At recruitment the Structured Clinical Interview for DSM-IV (SCID-IV) Mood disorders
schedule was undertaken [23]. In addition, the Edinburgh Postnatal Depression Scale (EPDS)
was administered at Waves 1, 2, 4 and 5 [24]. The scale is validated for use with Australian
women during the perinatal period[25]. The state anxiety subscale of the State-Trait Anxiety
Inventory (STAI) [26] was also administered at Waves 1, 2, 4 and 5. The STAI is validated
for use in Australian women in pregnancy [27].
2.1.2 Stressful Life Events
At Waves 1, 2, 4 and 5, women completed a 23-item stressful life events and social
health questionnaire [28] to determine incidence of both common and pregnancy-specific life
stressors. This scale has been adapted from Pregnancy Risk Assessment Monitoring System
(PRAMS) for the Australian context [29]. We grouped women into those who reported fewer
than 3 stressful life events at each Wave (< 3 SLE = 0), and those who reported 3 or more at
each wave up (≥ 3 SLE = 1). A systematic review suggested cortisol was more likely to be
associated with high levels of stress [10].
2.1.3 Antidepressant Use
Antidepressant type, usage, dosage and timing during pregnancy was self-reported by
women and obtained from hospital records at delivery. Maternal blood was collected and
analyzed for antidepressant drug levels and has previously been reported to confirm exposure
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[22, 30]. There were 43 women taking antidepressant medication across a range of
antidepressants, further details are published [22, 30].
2.1.4 Hair Cortisol
Maternal hair was collected post-delivery and maternal and infant hair at 12 months
postpartum. Maternal HCC from hair collected post-delivery is able to retrospectively
provide an average cortisol level for each trimester of pregnancy[31, 32]. HCC providing a
measure of chronic rather than short-term transient maternal physiological stress and is a
reliable and valid biomarker of mean cortisol concentrations [32]. A hair questionnaire was
administered at each collection to assess the recent use of bleaching, hair treatments including
products, dyes and hair washing, and corticosteroid use. Approximately 20grams (150
strands) of hair was collected from the posterior vertex of the scalp cut close to the scalp. At
least 5 mg of the most proximal 3 cm of hair was weighed for each hair sample. Samples
were processed and analyzed as described previously [33]. In short, in order to extract
cortisol from hair, all 3 cm-hair samples were cut into one-centimetre pieces and washed in
LC-MS grade isopropanol for 2 minutes. After solid phase extraction, hair cortisol was
quantified by liquid chromatography - tandem mass spectrometry using a Xevo TQ-S system
(Waters, Milford MA).
2.1.5 Salivary Cortisol Levels: Response and Reactivity
At 12 months of age, salivary samples in the infant were collected at three times during a
maternal-infant separation and reunion task: baseline (prior to mother and child beginning the
task after a rest period), 10 minutes after completing the task (+20 minutes from baseline),
and 30 minutes after completing the task (+40 minutes from baseline). At the commencement
of the task, the mother and child were left alone for three minutes to settle themselves in the
room, after which time the stranger entered, sitting silently for one minute, then talking for
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one minute and then playing for one minute. The task then comprised of two separations and
two reunions each at three-minute intervals. The stranger remained in the room for the
duration of the first separation, leaving at the first reunion. After a further three minutes, the
mother left the child alone in the room for three minutes until the second reunion. After
completing the separation and reunion task, parents were asked to free-play with their infant.
Salivary samples were collected using a salivette, centrifuged and stored at -80C.
Salivary cortisol was measured using a commercially available ELISA assay
(Salimetrics, USA), in duplicate according to the manufacturer’s instructions. Salivary
cortisol using these assays has been correlated well with matched serum cortisol
concentrations (r = .91). Assay sensitivity was 0.003 μg/dL, and intraassay variability was
4.4% and interassay variability was 4.9%. All salivary cortisol levels are expressed in SI
units, nmol/L.
Infant cortisol reactivity was expressed using two cortisol response indices, Area Under
the Curve relative to ground, or zero (AUCg), and AUC relative to increase (AUCi), using
equations outlined in Pruessner et al. [34]. AUCg and AUCi were introduced to capture a
single cortisol response measurement using repeated measurement data, and to attempt to
standardise the method for reporting change in cortisol so that findings could be easily
understood and compared across research [34, 35]. In this study, AUCg measures infant
cortisol response, that is an infants’ total cortisol levels during the period prior to
commencing and at 30 minutes after completing the task, whereas AUCi measures cortisol
reactivity, that is infants’ change in cortisol relative to their baseline cortisol level.
2.1.6 Social-emotional development.
The Brief Infant Toddler Social Emotional Assessment (BITSEA) is a parent report
questionnaire used to screen for social-emotional problems in young children aged 12 to 36
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months and was collected at 12 months for this study [36]. The BITSEA can be scored for
Internalizing and Externalizing Scales validated against the Preschool Age Psychiatric
Assessment, a diagnostic measure for mental health disorders in young children [36, 37].
2.2 Data Preparation and Statistical Analysis
During collection of the hair samples at birth and at 12 months postpartum, women reported
whether they had bleached their hair and whether they had taken any oral steroid medication. At birth,
13 women reported having bleached their hair during pregnancy, and at 12 months postpartum, 25
women reported bleaching their hair. In addition, 90 women reported treating their hair during
pregnancy, and at 12 months postpartum, 96 women reported treating their hair. Both bleaching and
treating hair during pregnancy and at 12 months postpartum was not associated with differences in
concurrent HCC (p > .05).

Prior to running inferential analyses using HCC, we log-transformed raw HCC due to
strong, negative skew of the distributions. Although these transformations improved negative
skew, there were between 3 and 4 women with univariate outliers (z ≥ |3|) in maternal HCC at
each wave during pregnancy. We recoded these outlying concentrations to missing to be
handled using Full-Information Maximum Likelihood estimation during modelling.
The four repeated HCC measures were fitted to a univariate latent-growth curve model,
adding depression diagnosis as a covariate of the growth factors. Next, we conducted
multivariate growth models to test for associations between changes in depressive and
anxious symptoms, and changes in maternal HCC during the perinatal period. Prior to
conducting this multivariate model, we fit the repeated measurements of depressive
symptoms and state anxiety to individual univariate latent growth curve models, and
individually added these univariate growth models to the HCC growth model to fit a parallel
process model.
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We next conducted a series of cross-lagged panel models to examine the lagged and
cross-sectional associations between repeated measurements of depressive symptoms and
maternal HCC, state anxiety and maternal HCC, and stressful life events and maternal HCC
during the perinatal period. These models also facilitate testing of indirect effects from
maternal mental health and stress to infant cortisol, through maternal HCC. Due to the large
number of hypotheses tests conducted for the estimated parameters across these three models,
we corrected for the False Discovery Rate (FDR) using the Benjamini-Hochberg procedure.
FDR-corrected significance (q-value < .10) was set at 10%.
All other tests were considered significant when p < .05. Due to non-normal
distributions, maximum-likelihood with robust standard errors (MLR) was used to estimate
models. Descriptive analyses were conducted using SPSS Version 24 [38] and all modelling
was conducted using Mplus version 8.
3. Results
3.1 Sociodemographic Data
Table 1 presents sociodemographic statistics for the total sample, and by group. Women
were all above 18 years old (Mage = 31.38, SDage = 4.66, ranging 19 – 48 years old).
3.2 Maternal Hair Cortisol Concentration (HCC) During Pregnancy and 12 Months
Postpartum
Inspection of observed log-transformed maternal HCC means suggested a non-linear
model would accurately describe the data. After fitting an intercept-only (χ2[d.f. = 8] =
325.52, p < .001, CFI = .36, RMSEA = .41, SRMR = 1.21) and linear slope model (χ2[d.f. = 6]
= 224.91, p < .001, CFI = .57, RMSEA = .39, SRMR = .15), adding a quadratic growth factor
resulted in the best-fitting model for the HCC data (χ2[d.f. = 2] = 17.58, p = .002, CFI = .97,
RMSEA = .18, SRMR = .04). In this unconditional non-linear model, the average of the
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intercept (M = 1.07, p < .001), slope (M = .25, p < .001) and quadratic factors (M = .05, p <
.001) were significant. These average change factors indicate starting maternal HCC was
significantly different from zero and increased significantly during pregnancy; however, this
initial rate of increase slowed significantly during pregnancy, and HCC levels decreased
between third trimester and 12 months postpartum. In addition, the variance estimates for
each of these growth factors were also significant, suggesting that women’s individual HCC
trajectories varied significantly (Intercept = 1.33, p <.001; Slope = .20, p <.001; Quadratic =
.005, p < .001). When added as a time-invariant covariate, a depression diagnosis was not a
significant predictor of starting (β = .04, p = .529), slope (β = -.13, p = .106) or quadratic (β =
.12, p = .119) maternal HCC growth factors.
Table 2 reports correlations between self-report antidepressant use in pregnancy at
recruitment and maternal and infant cortisol with no significant associations. Finally, using
only women taking antidepressants during pregnancy, antidepressant concentration in their
venous plasma taken directly after childbirth was not associated with their third trimester
maternal HCC, r(n = 39) = .08, p = .601. Table 2 also reports all bivariate zero-order Pearson
correlations between maternal and infant hair cortisol, maternal mental health and infant
stress reactivity at 12 months. Regarding infant salivary cortisol measurements during the
maternal-infant separation and reunion task, 67.1% of infants experienced an increase in
cortisol levels 10 minutes after completing the separation task (baseline: M = 3.32 nmol/L,
SD = 3.67 nmol/L; plus 20 minutes: M = 5.02 nmol/L, SD = 6.60 nmol/L; plus 40 minutes:
M = 4.92 nmol/L, SD = 4.26 nmol/L).
3.3 Maternal Mental Health and (HCC) During Pregnancy and to 12 Months
Postpartum
Figure 1 presents the correlations between growth factors in the multivariate parallel
process models for (a) maternal depressive symptoms and HCC, and (b) maternal state
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anxiety and HCC. Both the starting and the slope factors for maternal depressive symptoms
and state anxiety were uncorrelated with maternal HCC starting and slope change factors.
This suggests within a parallel process model that average changes in maternal HCC across
pregnancy were independent of average changes in maternal mental health symptoms during
the same period.
3.3.1 Perinatal Maternal Depressive Symptoms and HCC, and Infant Cortisol at 12
Months
Figure 2 displays the results of a model testing autoregressive, cross-sectional, and crosslagged associations between maternal depressive symptoms and HCC during the first
trimester and third trimester, and at 12 months postpartum. Infant cortisol measurements at
12 months postpartum were also included in the model as outcomes of maternal mental health
and HCC. Although not shown in the figure, we controlled for the effect of infant sex in each
of the three infant cortisol outcomes at 12 months postpartum. Infant sex was only
significantly associated with AUCi, such that male infants had lower AUCi. The
autoregressive association between first trimester and 12 month HCC suggests low stability
(i.e., considerable individual variability) in maternal HCC during the perinatal period. In
contrast, depressive symptoms across the same period were more stable, suggesting less
variance over time. At each time point, there were no cross-sectional associations between
depressive symptoms and maternal HCC. Higher maternal depressive symptoms during the
third trimester were also associated with significantly lower overall cortisol response (AUCg)
in the infant during the observational separation reunion task at 12 months. At 12 months,
there were also significant cross-sectional correlations, such that higher maternal HCC and
depressive symptoms were associated with higher infant HCC.
3.3.2 Perinatal State Anxiety Symptoms and HCC, and Infant Cortisol at 12 Months
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Figure 3 displays the results of a model testing autoregressive, cross-sectional, and crosslagged associations between maternal state anxiety and HCC during the first trimester and
third trimester, and at 12 months postpartum. Again, infant cortisol measurements at 12
months postpartum were also included in the model as outcomes of maternal constructs, with
significantly lower AUCi observed for male infants. Maternal state anxiety across the
perinatal period was less stable when compared to depressive symptoms in the previous
model; however, the autoregressive coefficient was significant, suggesting a degree of
stability over time. None of the cross-sectional or cross-lagged associations between state
anxiety and maternal HCC were significant, suggesting that maternal state anxiety and HCC
were relatively independent of each other during the perinatal period. Similar again to the
depressive symptoms model, higher maternal state anxiety during the third trimester was
associated with significantly lower overall cortisol response (AUCg) in the infant during the
task at 12 months.
3.3.3 Perinatal Stressful Life Events and HCC, and Infant Cortisol at 12 Months
Figure 4 displays the results of a model testing the autoregressive, cross-sectional and
lagged associations between maternal stressful life events and HCC during the first trimester
and third trimester, and at 12 months postpartum, and including infant 12 months cortisol
outcomes. This model differs to the depressive symptoms and state anxiety models above
because there is no basis to hypothesize that earlier HCC is predictive of later stressful life
events. As in the previous two models, infant sex was a significant predictor of AUCi. The
non-significant autoregressive coefficient for stressful life events suggests instability in the
construct during the perinatal period, such that reporting 3 or more stressful life events in
early pregnancy was not associated with reduced or increased odds of reporting 3 or more
stressful events at each subsequent time point. None of the cross-lagged or cross-sectional
paths from maternal stressful life events to HCC were significant, suggesting that maternal
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HCC was unrelated to reporting 3 or more stressful file events during the perinatal period.
Inconsistent with the pattern of associations in the depressive and anxiety symptoms models,
reporting 3 or more stressful life events during the third trimester was not associated with
significantly lower total cortisol response by the infant during the task at 12 months.
However, reporting 3 or more stressful life events at 12 months postpartum was crosssectionally associated with significantly lower infant HCC.
3.4 Infant Cortisol and Socio-emotional problems
Supplementary Table 1 reports bivariate correlations between infant cortisol measures;
infant HCC, infant saliva cortisol response and cortisol reactivity with BITSEA internalizing
and externalizing scales. Increased externalizing symptoms were found to be significantly
associated with lower infant cortisol reactivity. No other significant associations were
identified.
4. Discussion
This study presents unique data, including repeat maternal HCC in pregnancy and
postpartum, infant HCC, infant salivary cortisol and utilized diagnostic and self-report
measures of depression as well as anxiety, stress and antidepressant use for women and then a
maternal report of socio-emotional symptoms at 12 months for infants. Against prediction we
found no significant difference in maternal HCC across pregnancy and at 12 months
postpartum between women with a diagnosis of depression and control women. Likewise we
found no difference if women were taking antidepressant medication or not. However, early
pregnancy depressive symptoms, measured on the EPDS, predicted higher maternal HCC in
3rd trimester, while stress and anxiety symptoms had no impact on maternal HCC. Overall,
maternal HCC showed a small increase across pregnancy for all women with a subsequent
decline across the postpartum.
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In examining whether maternal perinatal mental health and cortisol predicted infant
cortisol outcomes, we found higher maternal late pregnancy HCC was associated with lower
cortisol reactivity in the infant at 12 months. Postpartum maternal HCC was also associated
with infant hair cortisol at 12 months. Furthermore, higher late pregnancy depressive and
anxiety symptoms were both associated with lower salivary cortisol response (AUCg) at 12
months of age in response to a separation-reunion task. While a recent systematic review did
not show a clear relationship between maternal perinatal depression and maternal cortisol,
what our data suggests is that maternal mental health symptoms are potentially important
mechanisms in pregnancy that influence HPA axis development and regulation in offspring
[8].
Our study also found infant salivary cortisol response at 12 months were lower where
there were an increased number of stressful life events in the postpartum but not in
pregnancy. A recent meta-analysis that examined all hair cortisol studies and a range of
mental health outcomes identified an increase in hair cortisol during chronic stress, while a
significant decrease in HCC was commonly observed with anxiety disorders and notably
PTSD [39]. They found less evidence for an effect on hair cortisol reported in studies
examining depression. Our findings show specifically that lower infant HCC and cortisol
response were both associated with late pregnancy maternal stress. Lower cortisol in children
has been associated with increased vulnerability to externalizing disorders and less
consistently with internalizing disorders [16]. In examining infant cortisol and symptoms of
externalizing or internalizing symptoms we found lower infant cortisol reactivity was crosssectionally associated with higher externalizing symptoms. This is an important finding, but
requires replication in older children, to ascertain any functional significance with regards
vulnerability to diagnostic mental disorders.
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Our measure of infant stress response and reactivity, measured through repeat salivary
cortisol was collected specifically in the context of a separation and reunion task with the
infant’s mother at 12 months of age. The importance of this early primary caregiver
relationship between mother and infant in the development of early stress regulation is likely
to be underpinned by a range of psychological and biological influences across early life.
These include in utero exposures to maternal stress regulation through cortisol, placental
functioning with regards cortisol transmission from mother to fetus and the quality and
security of the emerging mother-infant relationship which is postulated to buffer and
influence the development of infant stress regulation [40]. Although within this study we did
not assess attachment or the quality of the maternal-infant relationship, our findings did
indicate an association specifically of late pregnancy depression and anxiety symptoms with
lower overall infant cortisol response to a relational stress task. This suggests that a blunting
of cortisol response to separation and reunion with their mother when there were increased
maternal depressive and anxiety symptoms in late pregnancy, a response consistent with what
is observed with chronic rather than acute stress exposure [16, 41].
Intriguingly we also found a relationship between maternal and infant cortisol levels at
12 months postpartum. However maternal antenatal HCC was only associated with infant
cortisol reactivity measured through saliva samples and not with infant hair cortisol at 12
months. A previous study examined infant and maternal hair cortisol found an association
between late pregnancy maternal cortisol and infant hair cortisol at 1 years of age [42]. While
our study replicated this finding, it expanded by examining relationships between maternal
and infant cortisol also at 12 months postpartum finding also a cross-sectional association
within the dyad at this age. Synchrony and asynchrony of postpartum maternal and infant
cortisol has been associated with infant sleep practices, breastfeeding and the quality of the
dyadic relationship [43-45]. Overall this may continue to support a relationship between
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maternal perinatal cortisol and infant cortisol but this require further elucidation and
consideration of the potential genetic, epigenetic and environmental influences outside of
mental health.
The decision for women and clinicians on antidepressant treatment in pregnancy is
complex, however we found antidepressant use in pregnancy measured either as self-report
use or maternal blood levels at delivery was not associated with maternal or infant cortisol
levels. While this provides novel data as few studies have examined antidepressant exposure
and cortisol across the perinatal period, future studies could also examine specific agents,
dose and class of antidepressants.
Our study is limited by the lack of a diagnostic mental health outcome for offspring. For
those women taking antidepressants it was not possible to examine specific agents. While
powered for the analysis we undertook, a larger number of participants would allow greater
number of variables and complexity of models. Furthermore, this study does not include data
on fathers and given the importance of paternal mental health, parenting and support in early
development this is a limitation of this study[46]. While beyond the scope of this study we
have previously found an association between childhood trauma experiences and current
stressful life events and future research could explore this further[47]. This study did not
collect a diagnostic measure of Posttraumatic Stress Disorder (PTSD).
5. Conclusions
If we are to progress our understanding of the intergenerational mechanisms that may
underpin the association between maternal depression and child outcomes, future research
needs to build on this study by robustly measuring mental health and cortisol to reflect the
complexity of endocrinological systems that are dynamic and responsive to acute as well as
chronic environmental influences. Our findings highlight the importance of study design that
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does not rely on a single measure for either mental health or biological outcomes. Finally, the
largest gap is prospective research that includes robust and broad measures of mental health
in pregnancy, potential risk and protective mechanisms and measures of mental health in
children that include diagnostic as well as symptoms in children. Investing in this research is
likely to uncover how we can move forward in our goal of preventing mental disorders into
the next generation.
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Table 1. Demographic and Other Characteristics by Group (N = 241).
Not
Depressed
Depressed
(n = 190)
(n = 51)
a
n (% )
n (%a)
Ethnicity
Oceania/European
ATSI
Asian
Middle-eastern
Educational attainment
Did not complete high school
Completed tertiary certificate or
apprenticeship
Completed tertiary university
degree
Relationship status
Not currently in a relationship
Married (first)
Married (second or later)
De facto
Stable relationship but not living
together
Same-sex relationship
Separated
Employment status at recruitment
Full-time
Part-time
Casual
Unemployed
Studying
Full-time home duties
Smoking during pregnancy
BMI > 24 (overweight and obese) at
recruitment
Parity
Nulliparous
Primiparous
Multigravida
Pregnancy-induced hypertension
Infant sex (male)
EPDS
Early pregnancy

Total
Sample
(N = 241)
n (%a)

167 (88.4%)
1 (0.5%)
18 (9.5%)
3 (1.6%)

45 (88.2%)
1 (2.0%)
3 (5.9%)
2 (3.9%)

212 (88.3%)
2 (0.8%)
21 (8.8%)
5 (2.1%)

15 (8.0%)
44 (23.5%)

5 (10.0%)
17 (34.0%)

20 (8.5%)
61 (25.8%)

133 (65.8%)

28 (56.0%)

161 (67.7%)

5 (2.7%)
122 (65.2%)
5 (2.7%)
46 (24.6%)
6 (3.2%)

4 (8.0%)
29 (58%)
1 (2.0%)
13 (26.0%)
1 (2.0%)

9 (3.8%)
151 (63.7%)
6 (2.5%)
59 (24.9%)
7 (3.0%)

1 (0.5%)
2 (1.1%)

1 (2.0%)
1 (2.0%)

2 (0.8%)
3 (1.3%)

135 (72.2%)
25 (13.4%)
13 (7.0%)
4 (2.1%)
3 (1.6%)
3 (1.6%)
19 (10.2%)
90 (48.1%)

25 (50.0%)
8 (16.0%)
9 (18.0%)
3 (6.0%)
1 (2.0%)
1 (2.0%)
5 (10.0%)
32 (64.0%)

160 (67.5%)
33 (13.9%)
22 (9.3%)
7 (3.0%)
4 (1.7%)
4 (1.7%)
24 (89.8%)
122 (51.1%)

172 (91.0%)
10 (5.3%)
7 (3.7%)
5 (2.6%)
105 (55.3%)
M (SD)

46 (92.0%)
3 (6.0%)
1 (2.0%)
9 (17.6%)
28 (54.9%)
M (SD)

218 (91.2%)
13 (5.4%)
8 (3.3%)
14 (5.8%)
133 (55.2%)
M (SD)

5.57 (3.94)

10.00 (5.79)

6.48 (4.72)

25
Third trimester
Six months postpartum
12 months postpartum

5.48 (3.91)
5.30 (3.84)
5.76 (4.53)

9.14 (5.19)
8.25 (5.84)
9.34 (5.07)

6.24 (4.46)
5.93 (4.49)
6.42 (4.83)

Note. ATSI, Aboriginal and Torres Strait Islander; BMI, Body Mass Index, EPDS,
Edinburgh Postnatal Depression Scale.
a
Percent indicates percentage of full sample, including univariate missing.
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Table 2
Bivariate Zero-order Pearson Correlation Coefficients between Maternal Hair Cortisol, Mental Health Symptoms, Attachment and Parenting Stress during the Perinatal Period, and Infant Costrisol Measures at 12 months Postpartum.
Variable
Timepoint
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
1. Maternal Hair Cortisola

T1

-

2. Maternal Hair Cortisola

T2

.92**

-

3. Maternal Hair Cortisola

T3

.77**

.89**

-

4. Maternal Hair Cortisola

W5

.22**

.23**

.28**

-

5. Depression Diagnosis (SCID-IV)b

W1

.02

.01

-.04

.02

-

6. Antidepressant Treatmentb
7. EPDS
8. STAI (State)

W1
W1
W1

-.02
.02
.01

.00
.01
-.01

-.02
.09
.03

.04
.10
.04

.47**
.38**
.37**

.27**
.24**

.78**

-

9. ≥ 3 SLES
10. EPDS
11. STAI (State)

W1
W2
W2

.05
.01
-.01

.06
-.02
-.07

.05
.04
.00

.02
.03
-.02

.07
.33**
.27**

.05
.20**
.16*

.35**
.66**
.60**

.34**
.59**
.64**

.24**
.27**

.78**

-

12. ≥ 3 SLESb
13. EPDS
14. STAI (State)

W2
W4
W4

.09
-.06
-.02

.07
-.06
-.02

.08
-.04
-.01

.00
-.01
.00

.17**
.27**
.25**

.06
.22**
.13

.38**
.49**
.42**

.32**
.42**
.49**

.56**
.23**
.26**

.31**
.55**
.54**

.28**
.42**
.56**

.27**
.31**

.72**

-

15. ≥ 3 SLES
16. EPDS
17. STAI (State)

W4
W5
W5

-.01
-.03
-.08

-.02
-.06
-.09

.03
-.04
-.06

.01
.06
.08

.05
.29**
.37**

.04
.15*
.20**

.41**
.53**
.57**

.41**
.44**
.50**

.24**
.20**
.27**

.30**
.60**
.63**

.28**
.54**
.62**

.35**
.14*
.25**

.24**
.64**
.55**

.31**
.54**
.61**

.22**
.29**

.77**

-

18. ≥ 3 SLESb

W5

.03

-.02

-.07

-.10

.14*

-.01

.29**

.28**

.20**

.26**

.24**

.24**

.21**

.28**

.36**

.26**

.23**

-

19. Infant Sex (Male)b

Birth

.06

.07

.05

.11

.00

-.04

-.03

-.09

-.12

-.07

-.13*

-.12

-.05

-.07

-.09

.03

-.03

.03

-

20. Infant Hair Cortisola

W5

.09

.13

.01

.29**

.02

-.06

-.06

-.03

.08

-.09

-.06

-.01

-.03

-.13

-.14

.07

-.05

-.16*

.10

21. AUCga
22. AUCi
Mean
Standard Deviation
Range

W5
W5

b

b

20

21

22

-

-.07
-.08
-.14
-.03
-.06
-.01
-.17*
-.14
-.07
-.17* -.19* -.17*
-.08
-.18*
.00
-.05
-.10
-.10
-.02
.14
-.22** -.16*
-.13
-.12
-.08
.01
-.11
-.08
.04
-.02
-.02
.04
.02
-.01
-.05
-.06
-.05
-.03
-.19*
-.03
.53**
1.04
1.22
1.41
.90
.21
.18
6.48 34.81
.25
6.24 34.30
.21
5.93 31.75
.19
6.42 33.87
.19
.55
2.19
4.95
41.69
1.12
1.10
.97
.62
.41
.38
4.72 11.19
.44
4.46 10.52
.41
4.50
9.15
.39
4.83 10.27
.39
.50
1.50
.61
90.36
0.26- 0.26- 0.26- 0.260-1
0-1
0-27 20-75
0-1
0-25 20-73
0-1
0-24 20-58
0-1
0-25 20-60
0-1
0-1
0.263.83-195.19,
4.63
4.33
4.30
2.90
5.35
7.62
347.12
SCID-IV, Structured Clinical Interview for the Diagnostic and Statistical Manual of Mental Disorders, 4th Edition; EPDS, Edinburgh Postnatal Depression Scale; STAI, State-Strait Anxiety Scale - State Scale; SLES, Stressful Life Events; AUCg, Area Under the
Curve relative to Ground; AUCi, Area Under the Curve relative to Increase; T1, Trimester 1; T2, Trimester 2; T3, Trimester 3; W1, Wave 1 Early Pregnancy; W2, Wave 2 Trimester 3; W4, Wave 4 6 Month Postpartum; W5, Wave 5 12 Months Postpartum.
Missing data handled using case-wise deletion.
a

b

log-transformed, correlations with these variables are point-biserial.
** p < 0.01 * p < 0.05.
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(a)

(b)
Maternal HCC
Intercept
M = 1.07***
Var = 1.37***

-.44*** (.06)

Maternal HCC
Slope
M = .24***
Var = .20***

Maternal HCC
Intercept
M = 1.07***
Var = 1.36***

-.05 (.08)
-.02 (.08)

-.06 (.11)

-.21 (.14)

Maternal HCC
Slope
M = .25***
Var = .20***

.03 (.09)
-.00 (.07)

-.09 (.10)

Depressive
Symptoms
Intercept
M = 6.51***
Var = 13.61***

-.42*** (.06)

-.07 (.12)
-.10 (.12)

Depressive
Symptoms Slope
M = -.29
Var = .30***

State Anxiety
Intercept
M = 35.34***
Var = 75.31***

-.46*** (.12)

State Anxiety
Slope
M = -1.88***
Var = .97**

Figure 1. Parallel Process Models for (a) maternal depressive symptoms and HCC, and (b) maternal state anxiety and HCC. Path coefficients represent
correlations (and standard error). Greyed-out paths and parameter estimates are not significant. M, Mean; Var, Variance. Although a quadratic factor was
estimated for maternal HCC and depressive symptoms in (a) and for maternal HCC and state anxiety in (b), all correlations with quadratic terms were
constrained to zero in both models, and are, thus, not presented graphically. ** p < .01, ***p < .001.
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-.02 (.12)
Maternal HCC
(1st Trimester)

.77* (.03)

Maternal HCC
(3rd Trimester)

.31* (.12)

Maternal HCC
(12m pp.)

.02 (.08)
-.004 (.05)

-.13 (.07)

Infant HCC
(12m pp.)

.31* (.07)

-.11 (.06)
-.06 (.05)
AUCg
(12m pp.)

.01 (.07)
-.08 (.08)

-.18* (.07)

.08 (.04)

AUCi
(12m pp.)

-.04 (.07)
Depressive
Symptoms
(1st Trimester)

.66* (.04)

Depressive
Symptoms
(3rd Trimester)
.26* (.07)

.44* (.08)

Depressive
Symptoms
(12m pp.)

.58* (.08)

29
Figure 2. Cross-lag panel model results (standardised coefficients and standard error parenthetically) for Maternal HCC and Depressive Symptoms,
including Infant Cortisol Outcomes at 12 months only (N = 241). Greyed-out, dashed lines denote non-significant coefficients (FDR-controlled). Doubleheaded arrows represent correlation coefficients. Model fit: χ2(N = 241, d.f. = 14) = 14.69, p = .400, CFI = .999, RMSEA = .014, SRMS = .030. Although not
depicted in the figure, infant sex (Male = 1) controlled for in the infant cortisol outcomes at 12 months (i.e., Infant HCC, AUCg and AUCi).
*Benjamini-Hochberg FDR-controlled q-value < .10.
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-.02 (.12)
Maternal HCC
(1st Trimester)

.77* (.03)

Maternal HCC
(3rd Trimester)

.31* (.12)

Maternal HCC
(12m pp.)

.02 (.08)
-.04 (.05)

-.13 (.07)

Infant HCC
(12m pp.)

.30* (.07)

-.11 (.06)
-.08 (.05)
AUCg
(12m pp.)

.03 (.06)
-.05 (.07)

-.19* (.07)

.04 (.05)

AUCi
(12m pp.)

-.05 (.07)
State Anxiety
(1st Trimester)

.65* (.04)

State Anxiety
(3rd Trimester)
.18* (.08)

.49* (.07)

State Anxiety
(12m pp.)

.57* (.09)
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Figure 3. Cross-lag panel model results (standardised coefficients and standard error parenthetically) for Maternal HCC and State Anxiety, including Infant
Cortisol Outcomes at 12 months only (N = 241). Greyed-out, dashed lines denote non-significant coefficients (FDR-controlled). Double-headed arrows
represent correlation coefficients. Model fit: χ2(N = 241, d.f. = 14) = 14.07, p = .445, CFI = 1.000, RMSEA = .01, SRMS = .030. Although not depicted in the
figure, infant sex (Male = 1) controlled for in the infant cortisol outcomes at 12 months (i.e., Infant HCC, AUCg and AUCi).
*Benjamini-Hochberg FDR-controlled q-value < .10.
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-.01 (.07)
Maternal HCC
(1st Trimester)

.67* (.04)

Maternal HCC
(3rd Trimester)

.19* (.08)

Maternal HCC
(12m pp.)

-.01 (.12)
-.08 (.05)

-.13 (.10)

Infant HCC
(12m pp.)

.32* (.07)

-10.06 (6.11)
-.64* (.27)
AUCg
(12m pp.)

.17 (.19)
-.03 (.10)
.11 (.11)

-.02 (.09)
.15 (.25)

-.22 (.12)

AUCi
(12m pp.)

.32 (16.74)

4.81 (20.75)

.57* (.09)

-.10 (.18)
≥ 3 Stressful Life
Events (1st Trimester)

2.87* (.39)

≥ 3 Stressful Life
Events (3rd Trimester)
-.49 (.47)

1.05 (.48)

≥ 3 Stressful Life
Events (12m pp.)
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Figure 4. Results of the Stressful Life Events effects panel model (unstandardised coefficients and standard error parenthetically) for maternal HCC and
binary stressful life events (0 = Less than 3 SLE’s, 1 = ≥ 3 stressful life events), including Infant Cortisol Outcomes at 12 months only (N = 241). Pathways
representing prediction of SLES represent the log of the MLR estimate; exponentiating these estimates result in an odds ratio. Greyed-out, dashed lines
denote non-significant coefficients (FDR-controlled) . Double-headed arrows represent correlation coefficients. This model was estimated using the Monte
Carlo algorithm for parameter integration. Although not depicted in the figure, infant sex (Male = 1) controlled for in the infant cortisol outcomes at 12
months (i.e., Infant HCC, AUCg and AUCi).
*Benjamini-Hochberg FDR-controlled q-value < .10.
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